Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts’ new coverage for Wednesday, May 24th: StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Sanford C. Bernstein assumed coverage on shares of Ambev (NYSE:ABEV). They […]
Alimera Sciences (NASDAQ:ALIM – Get Rating) had its target price trimmed by HC Wainwright from $9.00 to $5.00 in a research report released on Friday, The Fly reports. HC Wainwright also issued estimates for Alimera Sciences’ Q2 2023 earnings at ($0.22) EPS, Q3 2023 earnings at ($0.19) EPS, Q4 2023 earnings at ($0.10) EPS, FY2023 […]
Alimera Sciences, Inc. (NASDAQ:ALIM – Get Rating) – Stock analysts at HC Wainwright increased their Q2 2023 earnings estimates for Alimera Sciences in a research note issued to investors on Tuesday, May 16th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will post earnings of ($0.22) per share for the quarter, up […]
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report report published on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on ALIM. HC Wainwright reissued a buy rating and set a $9.00 price target […]
Gainers Monogram Orthopaedics Inc. (NASDAQ:MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Or...